OpenEvidence hits $15B valuation, used by nearly two-thirds of US doctors

Ad-supported AI search platform OpenEvidence has reached a $15 billion valuation, with nearly two-thirds of US doctors using it to consult medical literature and clinical guidelines for patient care. The company said it processed over 42 million prompts last month, and its founder calls it the first viral consumer internet app in healthcare.

• OpenEvidence partners with Anthropic, Penn Medicine to expand AI in Africa and Asia2026-09-28
• Anthropic, OpenEvidence partner to bring medical AI worldwide2026-09-22
• JAMA study: OpenEvidence clinical use surges over two years2026-10-19
• Sutter Health Expands Clinical AI and Medical School Plans2026-09-13